Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: Findings from the 2012 Canadian Community Health Survey - Mental Health (CCHS-MH)

Journal of Psychosomatic Research

Volumn 78, Issue 2, 2015, Pages 137-142

  Deschênes, Sonya S ^a,b   Burns, Rachel J ^a,b   Schmitz, Norbert ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

2012 canadian community health survey; Comorbidity; Diabetes; Disability; Generalized anxiety disorder; Major depressive disorder

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISABILITY; FEMALE; GENERALIZED ANXIETY DISORDER; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; SELF REPORT; ANXIETY DISORDERS; CANADA; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; DISABLED PERSON; INDEPENDENT LIVING; MENTAL HEALTH; PSYCHOLOGY; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ANXIETY DISORDERS; CANADA; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS; DISABLED PERSONS; FEMALE; HEALTH SURVEYS; HUMANS; INDEPENDENT LIVING; LOGISTIC MODELS; MALE; MENTAL HEALTH; MIDDLE AGED; SOCIOECONOMIC FACTORS;

EID: 84921000190     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2014.11.023     Document Type: Article

References (44)

1. Barnard KD, Skinner TC, Peveler R The prevalence of co-morbid depression in adults with type 1 diabetes: systematic literature review. Diabet. Med. 2006, 23:445-448.
2. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001, 24:1069-1078.
3. Roy T, Lloyd CE Epidemiology of depression and diabetes: a systematic review. J. Affect. Disord. 2012, 142:S8-S21.
4. Ali N, Jyotsna VP, Kumar N, Mani K Prevalence of depression among type 2 diabetes compared to healthy nondiabetic controls. J. Assoc. Physicians India 2013, 61:619-621.
5. Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 2010, 53:2480-2486.
6. Mezuk B, Eaton WW, Albrecht S, Golden SH Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008, 31:2383-2390.
7. Pouwer F, Beekman AT, Nijpels G, Dekker JM, Snoek FJ, Kostense PJ, et al. Rates and risks for co-morbid depression in patients with type 2 diabetes mellitus: results from a community-based study. Diabetologia 2003, 46:892-898.
8. Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006, 49:837-845.
9. Schmitz N, Gariepy G, Smith KJ, Clyde M, Malla A, Boyer R, et al. Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes. Diabetes Care 2014, 37:970-978.
10. Hoffman DL, Dukes EM, Wittchen HU Human and economic burden of generalized anxiety disorder. Depress. Anxiety 2008, 25:72-90.
11. Wittchen HU Generalized anxiety disorder: prevalence, burden, and cost to society. Depress. Anxiety 2002, 16:162-171.
12. Hendriks SM, Spijker J, Licht CM, Beekman AT, Hardeveld F, de Graaf R, et al. Disability in anxiety disorders. J. Affect. Disord. 2014, 166:227-233.
13. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Jam. 2003, 289:3095-3105.
14. Kessler RC, Berglund P, Chiu WT, Demler O, Heeringa S, Hiripi E, et al. The US National Comorbidity Survey Replication (NCS-R): design and field procedures. Int. J. Methods Psychiatr. Res. 2004, 13:69-92.
15. Maia AC, Braga Ade A, Paes F, Machado S, Nardi AE, Silva AC Psychiatric comorbidity in diabetes type 1: a cross-sectional observational study. Rev. Assoc. Med. Bras. 2014, 60:59-62.
16. Smith KJ, Beland M, Clyde M, Gariepy G, Page V, Badawi G, et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J. Psychosom. Res. 2013, 74:89-99.
17. Engum A The role of depression and anxiety in onset of diabetes in a large population-based study. J. Psychosom. Res. 2007, 62:31-38.
18. Butnoriene J, Bunevicius A, Norkus A, Bunevicius R Depression but not anxiety is associated with metabolic syndrome in primary care based community sample. Psychoneuroendocrinology 2014, 40:269-276.
19. Edwards LE, Mezuk B Anxiety and risk of type 2 diabetes: evidence from the Baltimore Epidemiologic Catchment Area Study. J. Psychosom. Res. 2012, 73:418-423.
20. Norton PJ, Mehta PD Hierarchical model of vulnerabilities for emotional disorders. Cogn. Behav. Ther. 2007, 36:240-254.
21. Clark LA, Watson D Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J. Abnorm. Psychol. 1991, 100:316-336.
22. Clark LA, Watson D, Mineka S Temperament, personality, and the mood and anxiety disorders. J. Abnorm. Psychol. 1994, 103:103-116.
23. Miller GA, Chapman JP Misunderstanding analysis of covariance. J. Abnorm. Psychol. 2001, 110:40-48.
24. Lamers F, van Oppen P, Comijs HC, Smit JH, Spinhoven P, van Balkom AJ, et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J. Clin. Psychiatry 2011, 72:341-348.
25. Bhattacharya R, Shen C, Sambamoorthi U Excess risk of chronic physical conditions associated with depression and anxiety. BMC Psychiatry 2014, 14:10.
26. Lecrubier Y Widespread underrecognition and undertreatment of anxiety and mood disorders: results from 3 European studies. J. Clin. Psychiatry 2007, 68:36-41.
27. Li C, Ford ES, Zhao G, Ahluwalia IB, Pearson WS, Mokdad AH Prevalence and correlates of undiagnosed depression among U.S. adults with diabetes: the Behavioral Risk Factor Surveillance System, 2006. Diabetes Res. Clin. Pract. 2009, 83:268-279.
28. Penninx BW, Leveille S, Ferrucci L, van Eijk JT, Guralnik JM Exploring the effect of depression on physical disability: longitudinal evidence from the established populations for epidemiologic studies of the elderly. Am. J. Public Health 1999, 89:1346-1352.
29. Von Korff M, Ormel J, Katon W, Lin EH Disability and depression among high utilizers of health care. A longitudinal analysis. Arch. Gen. Psychiatry 1992, 49:91-100.
30. Lecrubier Y The burden of depression and anxiety in general medicine. J. Clin. Psychiatry 2001, 62:4-9. [discussion 10-1].
31. Canada S Canadian Community Health Survey (CCHS)-mental health user guide 2013, Ottawa, Statistics Canada.
32. Schmitz N, Wang J, Malla A, Lesage A The impact of psychological distress on functional disability in asthma: results from the Canadian community health survey. Psychosomatics 2009, 50:42-49.
33. Kessler RC, Ustun TB The World Mental Health (WMH) survey initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int. J. Methods Psychiatr. Res. 2004, 13:93-121.
34. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV-TR 2000, American Psychiatric Association, Washington, DC.
35. Raedler TJ Inflammatory mechanisms in major depressive disorder. Curr. Opin. Psychiatry 2011, 24:519-525.
36. Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis. Psychol. Med. 2012, 42:2641-2650.
37. Lasic D, Bevanda M, Bosnjak N, Uglesic B, Glavina T, Franic T Metabolic syndrome and inflammation markers in patients with schizophrenia and recurrent depressive disorder. Psychiatr. Danub. 2014, 26:214-219.
38. Rhee SJ, Kim EY, Kim SH, Lee HJ, Kim B, Ha K, et al. Subjective depressive symptoms and metabolic syndrome among the general population. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 54:223-230.
39. Beyazyuz M, Albayrak Y, Egilmez OB, Albayrak N, Beyazyuz E Relationship between SSRIs and metabolic syndrome abnormalities in patients with generalized anxiety disorder: a prospective study. Psychiatry Investig. 2013, 10:148-154.
40. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the study of obesity. Circulation 2009, 120:1640-1645.
41. Pelletier C, Dai S, Roberts KC, Bienek A, Onysko J, Pelletier L Report summary. Diabetes in Canada: facts and figures from a public health perspective. Chron.dis Inj. Can. 2012, 33:53-54.
42. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 1993, 329:977-986.
43. Mezuk B, Johnson-Lawrence V, Lee H, Rafferty JA, Abdou CM, Uzogara EE, et al. Is ignorance bliss? Depression, antidepressants, and the diagnosis of prediabetes and type 2 diabetes. Health Psychol. 2013, 32:254-263.
44. Psychiatric Association American Diagnostic and statistical manual of mental disorders: DSM-5 2013, American Psychiatric Association, Washington, DC. 5th ed.